Search clinical trials for: Pomalidomide
Total 261 results
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
Kirby InstituteActive, not recruitingHigh Grade Squamous Intra-epithelial Lesion (HSIL)Australia
-
Amsterdam UMC, location VUmcNot yet recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
CelgeneTerminatedSystemic Sclerosis | Scleroderma, Systemic | Systemic Scleroderma | Interstitial Lung Disease | Sclerosis, SystemicUnited States, Spain, France, Australia, Italy, Switzerland, Germany, Poland, United Kingdom, Russian Federation
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
CelgeneCompletedMultiple MyelomaBelgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Second Hospital of Shanxi Medical UniversityCompleted
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
CelgeneCompletedAnemia, Sickle CellUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
CelgeneCompleted
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
Zhejiang DTRM BiopharmaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter's Transformation | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
The Royal Wolverhampton Hospitals NHS TrustUniversity of WolverhamptonRecruiting
-
The Cleveland ClinicRTI InternationalCompletedTelangiectasia, Hereditary HemorrhagicUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingRelapsed or Refractory (R/R) Primary Central Nervous System LymphomaChina
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
National Cancer Institute (NCI)Active, not recruitingKaposi SarcomaUnited States
-
Peking University People's HospitalQingdao Municipal HospitalRecruiting
-
Seagen Inc.Terminated
-
National University Hospital, SingaporeCelgeneUnknownMultiple Myeloma | Relapse After Use of Lenalidomide and BortezomibSingapore
-
IRCCS Policlinico S. MatteoCompletedPrimary Amyloidosis of Light Chain TypeItaly
-
Shanxi Bethune HospitalRecruiting
-
Onward TherapeuticsRecruitingSolid Tumor | Hematological MalignancyFrance
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
National Cancer Institute (NCI)CompletedGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States
-
LanZhou UniversityBeijing Health Alliance Charitable FoundationRecruitingMultiple MyelomaChina
-
Natalie CallendarBristol-Myers SquibbWithdrawn
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruiting
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
National Cancer Institute (NCI)CompletedSarcoma, Kaposi | Kaposi SarcomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Fondazione EMN Italy OnlusCompleted
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
CelgeneTerminatedSoft Tissue SarcomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of UlmActive, not recruitingPrimary Myelofibrosis | Secondary Myelofibrosis | Post-PV MF | PMF | SMF | Post-ET MFGermany
-
The Cleveland ClinicCompletedHereditary Hemorrhagic Telangiectasia | Idiopathic Vascular EctasiaUnited States
-
University of ArkansasCelgeneCompletedMultiple MyelomaUnited States